Cite
NONO2P, a novel nitric oxide donor, causes vasorelaxation through NO/sGC/PKG pathway, K + channels opening and SERCA activation.
MLA
Moraes, Raiana A., et al. “NONO2P, a Novel Nitric Oxide Donor, Causes Vasorelaxation through NO/SGC/PKG Pathway, K + Channels Opening and SERCA Activation.” European Journal of Pharmacology, vol. 979, Sept. 2024, p. 176822. EBSCOhost, https://doi.org/10.1016/j.ejphar.2024.176822.
APA
Moraes, R. A., Brito, D. S., Araujo, F. A., Jesus, R. L. C., Silva, L. B., Sá, D. S., Silva da Silva, C. D., Pernomian, L., Wenceslau, C. F., Priviero, F., Webb, R. C., & Silva, D. F. (2024). NONO2P, a novel nitric oxide donor, causes vasorelaxation through NO/sGC/PKG pathway, K + channels opening and SERCA activation. European Journal of Pharmacology, 979, 176822. https://doi.org/10.1016/j.ejphar.2024.176822
Chicago
Moraes, Raiana A, Daniele S Brito, Fênix A Araujo, Rafael L C Jesus, Liliane B Silva, Denise S Sá, Carlos D Silva da Silva, et al. 2024. “NONO2P, a Novel Nitric Oxide Donor, Causes Vasorelaxation through NO/SGC/PKG Pathway, K + Channels Opening and SERCA Activation.” European Journal of Pharmacology 979 (September): 176822. doi:10.1016/j.ejphar.2024.176822.